ArticleTropical medicine and health2026
Antimicrobial activity of Vepris salicifolia leaf essential oil and δ-cadinene: in vitro evaluation and in silico mechanistic insights into δ-cadinene.
Article in Tropical medicine and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe emergence of antimicrobial resistance has intensified the search for new bioactive compounds from natural sources. This study investigated the chemical composition and antimicrobial activity of the essential oil (EO) extracted from the leaves of Vepris salicifolia (Engl.) Mziray. In addition, the molecular interactions and drug-like properties of δ-cadinene, the major constituent of the EO, were evaluated.
methodsThe EO was extracted by hydrodistillation and subsequently characterized chemically using gas chromatography-mass spectrometry (GC-MS). The antibacterial and antifungal activities of the EO and δ-cadinene were assessed using disc diffusion and agar dilution assays, while molecular docking and ADMET analyses were performed to elucidate the potential mechanism of antimicrobial action and evaluate the pharmacokinetic and drug-likeness properties of δ-cadinene.
resultsGC-MS analysis identified 26 compounds, representing 84.3% of the EO. The predominant constituents were δ-cadinene (23.5%), intermedeol (18.3%), germacrene D (10.2%), α-muurolol (9.0%), and germacrene D-4-ol (7.5%). The EO and δ-cadinene effectively inhibited the growth of a wide range of Gram-positive and Gram-negative bacteria and fungi. Notably, δ-cadinene showed antibacterial activity against S. aureus ML267, with an inhibition zone of 17.8 mm, comparable to that of ciprofloxacin (18.0 mm). Furthermore, the EO exhibited greater antifungal activity against Penicillium notatum, with an inhibition zone of 14.0 mm compared with 11.0 mm for griseofulvin. Docking results showed favorable binding energies for δ-cadinene with the CrtM enzyme of S. aureus (- 7.757 kcal/mol) and the CYP51 enzyme of P. notatum (- 5.756 kcal/mol). ADMET studies further revealed that δ-cadinene has favorable drug-like characteristics, including high intestinal permeability and oral bioavailability, and did not predict any cardiotoxicity.
conclusionThe findings of this study indicate that V. salicifolia leaf EO, particularly δ-cadinene, represents a promising source of antimicrobial agents for future medicinal applications. Nevertheless, the predicted molecular mechanisms of δ-cadinene should be validated through enzyme inhibition assays.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.